Rocket Pharmaceuticals Inc Headquarters
Looking for information about Rocket Pharmaceuticals Inc Headquarters? The links below have collected all the necessary data.
Contact Us Rocket Pharmaceuticals
- https://rocketpharma.com/contact-us/
- R&D and Corporate Headquarters 9 Cedarbrook Drive Cranbury, NJ 08512. The Empire State Building 350 Fifth Avenue, Suite 7530 New York, NY 10118. p: 646.440.9100. First Name. Last Name. Email Address. Phone Number. Message. Terms. I Agree to Rocket's Terms and Conditions. SUBMIT. Rocket Pharmaceuticals, Inc. R&D and Corporate Headquarters 9 ...
Home Rocket Pharmaceuticals
- https://rocketpharma.com/
- The Rocket team possesses decades of experience and leadership in the biotech industry. This expertise, combined with our passion, creativity, a commitment to patients and curiosity, has enabled us to grow at an unprecedented rate and move five programs into the clinic in just two years.Estimated Reading Time: 2 mins
About Us Rocket Pharmaceuticals
- https://rocketpharma.com/about-us/
- Jul 14, 2015 · Previously, he served as President, Chief Executive Officer, Board member of Inotek Pharmaceuticals from July 2014 until Inotek merged with Rocket in January 2018. From March 2010 to October 2012, Mr. Southwell served as Executive Vice President, Chief Financial Officer of Human Genome Sciences, Inc. until its merger with GlaxoSmithKline plc.Estimated Reading Time: 2 mins
Careers Rocket Pharmaceuticals
- https://rocketpharma.com/join-us/careers/
- R&D and Corporate Headquarters 9 Cedarbrook Drive Cranbury, NJ 08512. The Empire State Building 350 Fifth Avenue, Suite 7530 New York, NY 10118
Investor Overview Rocket Pharmaceuticals, Inc.
- https://ir.rocketpharma.com/
- May 10, 2021 · Corporate Profile. Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral virus, which we refer to as LVV, adeno-associated virus ...
Rocket Pharmaceuticals Announces $26.4 Million Private ...
- https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-264-million-private-placement
- Aug 27, 2021 · CRANBURY, N.J.--(BUSINESS WIRE)--Aug. 30, 2021-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces a securities purchase agreement with a fund affiliated with RTW Investments, LP, the Company’s largest shareholder, for the purchase of an …
Events & Presentations Rocket Pharmaceuticals, Inc.
- https://ir.rocketpharma.com/events-presentations
- Dec 07, 2020 · R&D and Corporate Headquarters 9 Cedarbrook Drive Cranbury, NJ 08512. The Empire State Building 350 Fifth Avenue, Suite 7530 New York, NY 10118
Our Disease Focus Rocket Pharmaceuticals
- https://rocketpharma.com/our-disease-focus/
- Our Disease Focus. Rocket’s pipeline is comprised of first-in-class gene therapies for rare and devastating, inherited genetic diseases. Rocket is platform-agnostic, meaning we choose the most practical gene therapy platform for the disease being targeted. Each program is intended to be transformative, enabling not only reversal of the ...Estimated Reading Time: 5 mins
News Release Details - Rocket Pharmaceuticals, Inc.
- https://rocketpharmaceuticals.gcs-web.com/news-releases/news-release-details/rocket-pharmaceuticals-receives-fda-fast-track-designation-rp
- —Rocket’s Fifth Gene Therapy Program Receives Fast Track Designation— NEW YORK--(BUSINESS WIRE)--Aug. 27, 2020-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
News Releases Rocket Pharmaceuticals, Inc.
- https://ir.rocketpharma.com/news-releases
- Mar 29, 2021 · Rocket Pharmaceuticals Announces $26.4 Million Private Placement. Aug 16, 2021. Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501. Aug 09, 2021. Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress. Aug 03, 2021. Rocket Pharmaceuticals to Host Conference ...
Have you found Rocket Pharmaceuticals Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.